Characterization of drug-loaded alginate-chitosan polyelectrolyte nanoparticles synthesized by microfluidics

被引:11
|
作者
Zamani, Mohammad Hossein [1 ]
Khatibi, Alireza [1 ]
Tavana, Beeta [1 ]
Zahedi, Payam [1 ]
Aghamohammadi, Shayesteh [1 ]
机构
[1] Univ Tehran, Coll Engn, Sch Chem Engn, Nanobiopolymers Res Lab, POB 11155-4563, Tehran, Iran
关键词
Microfluidics; Bulk mixing; 5-fluorouracil; Alginate; Chitosan; POLYMERIC NANOPARTICLES; RELEASE FORMULATIONS; ORAL DELIVERY; IN-VITRO; 5-FLUOROURACIL; ENCAPSULATION; COMPLEXES; OPTIMIZATION; PLATFORM;
D O I
10.1007/s10965-023-03468-1
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In this study, the microfluidic approach (MF) and the bulk mixing method (BM) were utilized to synthesize 5-fluorouracil (5-FU)-loaded alginate-chitosan (Alg-CS) polyelectrolyte-based nanoparticles (NPs). Characterization studies revealed that MF NPs obtained a smaller mean diameter (similar to 115 nm), narrower polydispersity index (0.14), and also a higher zeta potential (-38 mV) compared with BM NPs. Furthermore, drug encapsulation efficiency (EE) and drug loading capacity (LC) were both higher for MF NPs (%84 and %11, respectively). Moreover, convenient compatibility between 5-FU and Alg-CS was evidenced via fourier transform infrared spectroscopy (FTIR) test. In vitro release studies coupled with its kinetics revealed that drug release from MF NPs not only experienced a lower burst release (%4 after 30 min) but also a more controlled release (%29 after 8 h), and in turn, its release behavior followed the Higuchi model at different pHs. Eventually, due to the desirable properties of MF NPs, they can be considered a reliable drug delivery system for the controlled release of 5-FU.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Breast cancer drug delivery by novel drug-loaded chitosan-coated magnetic nanoparticles
    Taherian, A.
    Esfandiari, N.
    Rouhani, S.
    CANCER NANOTECHNOLOGY, 2021, 12 (01)
  • [42] Development and Characterization of Anti-alzheimer Drug-loaded Chitosan Nanoparticles for the Enhanced Penetration of Blood Brain Barrier
    Raja, Maria Abdul Ghafoor
    Amjad, Muhammad Wahab
    Alotaibi, Nawaf Mohamed
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (15) : 33 - 39
  • [43] Breast cancer drug delivery by novel drug-loaded chitosan-coated magnetic nanoparticles
    A. Taherian
    N. Esfandiari
    S. Rouhani
    Cancer Nanotechnology, 2021, 12
  • [44] Drug-loaded polymeric nanoparticles: a review
    de Castro, Karine Cappuccio
    Costa, Josiel Martins
    Campos, Maria Gabriela Nogueira
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2022, 71 (01) : 1 - 13
  • [45] Ciprofloxacin Loaded Alginate/Chitosan and Solid Lipid Nanoparticles, Preparation, and Characterization
    Ghaffari, Solmaz
    Varshosaz, Jaleh
    Haririan, Ismaeil
    Khoshayand, Mohammad Reza
    Azarmi, Shirzad
    Gazori, Taraneh
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2012, 33 (05) : 685 - 689
  • [46] Effect of the preparation method on the drug loading of alginate-chitosan microspheres
    Abreu, F. O. M. S.
    Forte, M. M. C.
    Kist, T. B. L.
    Honaiser, L. P.
    EXPRESS POLYMER LETTERS, 2010, 4 (08): : 456 - 464
  • [47] DRUG-LOADED ALGINATE MICROSPHERES FOR BREAST CANCER TREATMENT
    Catalano, Delia
    Dalfino, Sophia
    Pitton, Matteo
    Fare, Silvia
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 611 - 612
  • [48] Preparation and characterization of sodium alginate/polyvinyl alcohol hydrogel containing drug -loaded chitosan nanoparticles as a drug delivery system
    Afshar, M.
    Dini, G.
    Vaezifar, S.
    Mehdikhani, M.
    Movahedi, B.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 56
  • [49] A novel drug carrier:: Lipophilic drug-loaded polyglutamate/polyelectrolyte nanocontainers
    Teng, Xin Rong
    Shchukin, Dmitry G.
    Moehwald, Helmuth
    LANGMUIR, 2008, 24 (02) : 383 - 389
  • [50] Preparation and characterization of drug-loaded chitosan-tripolyphosphate microspheres by spray drying
    Desai, KGH
    Park, HJ
    DRUG DEVELOPMENT RESEARCH, 2005, 64 (02) : 114 - 128